back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-12-04 16:43 Tx date 2024-11-29 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+20,224 vol |
45,224 | |
| Filed 2024-12-04 16:42 Tx date 2024-11-29 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-75,000 vol |
301,346 | |
| Filed 2024-09-27 16:09 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
376,346 | |
| Filed 2023-10-02 21:40 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
276,346 | |
| Filed 2022-10-17 13:13 Tx date 2022-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-21,875
-12,500 vol $1.75 each |
0 | |
| Filed 2022-06-28 15:57 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
176,346 | |
| Filed 2021-09-24 16:12 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
117,725 | |
| Filed 2020-11-05 09:09 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
90,655 | |
| Filed 2019-11-11 16:17 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+75,000 vol $1.30 each |
75,000 | |
| Filed 2019-11-11 16:17 Tx date 2019-09-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-18 14:22 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$21,875
+12,500 vol $1.75 each |
12,500 | |
| Filed 2019-10-18 14:22 Tx date 2019-09-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-18 14:22 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$32,500
+25,000 vol $1.30 each |
25,000 | |
| Filed 2019-10-18 14:21 Tx date 2019-09-24 |
$MDNA
Medicenna Therapeutics Corp. |
Dawes, Karen
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|